ETHK Labs Inc. (HKG:1931)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.180
+0.030 (2.61%)
Mar 10, 2026, 1:22 PM HKT
-33.33%
Market Cap 1.84B
Revenue (ttm) 3.37B
Net Income (ttm) 190.94M
Shares Out 1.60B
EPS (ttm) 0.12
PE Ratio 9.83
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,767,000
Average Volume 4,535,675
Open 1.140
Previous Close 1.150
Day's Range 1.140 - 1.210
52-Week Range 1.090 - 12.860
Beta -0.52
RSI 34.97
Earnings Date Mar 16, 2026

About ETHK Labs

ETHK Labs Inc., an investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally. The company operates through three segments: Distribution Business, After-sales Services, and Self-branded Products Business. It offers IVD analysers, reagents, and other consumables for various IVD testing categories, including hematology and body fluid, immunoassay, clinical chemistry, immunology, microbiology, and point-of-care testing. The company also provides haemostasis products; solution services to the cl... [Read more]

Sector Healthcare
Founded 1993
Employees 877
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1931
Full Company Profile

Financial Performance

In 2024, ETHK Labs's revenue was 3.16 billion, an increase of 2.40% compared to the previous year's 3.09 billion. Earnings were 260.42 million, an increase of 9.35%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.